NYSE - Delayed Quote USD

Prestige Consumer Healthcare Inc. (PBH)

70.47 +0.33 (+0.47%)
At close: April 26 at 4:00 PM EDT
70.47 0.00 (0.00%)
After hours: April 26 at 5:59 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
3/31/2023
3/31/2022
3/31/2021
Total Revenue
1,134,235.00
1,127,725.00
1,086,812.00
943,365.00
Cost of Revenue
507,840.00
502,431.00
466,166.00
395,893.00
Gross Profit
626,395.00
625,294.00
620,646.00
547,472.00
Operating Expense
276,899.00
277,492.00
289,670.00
247,636.00
Operating Income
349,496.00
347,802.00
330,976.00
299,836.00
Net Non Operating Interest Income Expense
-70,876.00
-69,164.00
-64,287.00
-82,328.00
Other Income Expense
-369,439.00
-372,553.00
-4,231.00
-13,395.00
Pretax Income
-90,819.00
-93,915.00
262,458.00
204,113.00
Tax Provision
-10,148.00
-11,609.00
57,077.00
39,431.00
Net Income Common Stockholders
-80,671.00
-82,306.00
205,381.00
164,682.00
Diluted NI Available to Com Stockholders
-80,671.00
-82,306.00
205,381.00
164,682.00
Basic EPS
-1.61
-1.65
4.09
3.28
Diluted EPS
-1.61
-1.65
4.04
3.25
Basic Average Shares
49,748.00
49,889.00
50,259.00
50,210.00
Diluted Average Shares
49,748.00
49,889.00
50,842.00
50,605.00
Total Operating Income as Reported
-20,721.00
-22,415.00
329,919.00
297,402.00
Total Expenses
784,739.00
779,923.00
755,836.00
643,529.00
Net Income from Continuing & Discontinued Operation
-80,671.00
-82,306.00
205,381.00
164,682.00
Normalized Income
248,178.42
242,004.09
207,870.16
176,594.13
Interest Income
365.00
--
--
--
Interest Expense
70,876.00
69,164.00
64,287.00
82,328.00
Net Interest Income
-70,876.00
-69,164.00
-64,287.00
-82,328.00
EBIT
-19,943.00
-24,751.00
326,745.00
286,441.00
EBITDA
10,752.00
7,874.00
358,837.00
316,605.00
Reconciled Cost of Revenue
500,024.00
494,883.00
458,942.00
389,670.00
Reconciled Depreciation
30,695.00
32,625.00
32,092.00
30,164.00
Net Income from Continuing Operation Net Minority Interest
-80,671.00
-82,306.00
205,381.00
164,682.00
Total Unusual Items Excluding Goodwill
-370,217.00
-370,217.00
-3,179.00
-14,761.00
Total Unusual Items
-370,217.00
-370,217.00
-3,179.00
-14,761.00
Normalized EBITDA
380,969.00
378,091.00
362,016.00
331,366.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-41,367.58
-45,906.91
-689.84
-2,848.87
3/31/2021 - 2/10/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TARO Taro Pharmaceutical Industries Ltd.
42.40
-0.19%
 
KMDA Kamada Ltd.
5.15
-0.96%
 
HLS.TO HLS Therapeutics Inc.
4.6500
-1.69%
 
APH.L Alliance Pharma plc
34.95
+0.14%
 
LFCR Lifecore Biomedical, Inc.
6.60
-0.68%
 
HCM HUTCHMED (China) Limited
18.16
-4.37%
 
AMPH Amphastar Pharmaceuticals, Inc.
41.11
+0.69%
 
RDY Dr. Reddy's Laboratories Limited
74.55
+0.72%
 
HUGE.CN FSD Pharma Inc.
0.6600
0.00%
 
CTLT Catalent, Inc.
55.92
+0.22%